Yes. The word exosomes only more recently came into use. While we are now recently emphasizing them in our communications due to rising public interest, exosome technology has been incorporated into iS Clinical formulations for some time—reflecting our commitment to clinically advanced, evidence-based innovation. It is important to recognize that exosomes are one component within a broad synergy of advanced, clinically proven ingredients that make up the final formulation. Their role is significant, but it is the precision of the entire formulation that drives iS Clinical’s performance and results.